<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>myeloid Archives - Good News!</title>
	<atom:link href="https://goodnewsplanet.com/tag/myeloid/feed/" rel="self" type="application/rss+xml" />
	<link>https://goodnewsplanet.com/tag/myeloid/</link>
	<description>Life Affirming Good News</description>
	<lastBuildDate>Thu, 05 Jun 2025 22:29:14 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://goodnewsplanet.com/wp-content/uploads/2022/04/cropped-Earth-1200-×-1200-px-32x32.png</url>
	<title>myeloid Archives - Good News!</title>
	<link>https://goodnewsplanet.com/tag/myeloid/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>LEUKEMIA IS A TYPE OF CANCER THAT AFFECTS THE BLOOD OR BONE MARROW.</title>
		<link>https://goodnewsplanet.com/leukemia-is-a-type-of-cancer-that-affects-the-blood-or-bone-marrow/</link>
		
		<dc:creator><![CDATA[Austin Tang]]></dc:creator>
		<pubDate>Mon, 02 Jun 2025 16:29:33 +0000</pubDate>
				<category><![CDATA[Good News To Go]]></category>
		<category><![CDATA[Health and Wellness]]></category>
		<category><![CDATA[Peace]]></category>
		<category><![CDATA[affect]]></category>
		<category><![CDATA[blood]]></category>
		<category><![CDATA[bone]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[carolina]]></category>
		<category><![CDATA[cellular]]></category>
		<category><![CDATA[chronic]]></category>
		<category><![CDATA[critical]]></category>
		<category><![CDATA[department]]></category>
		<category><![CDATA[health]]></category>
		<category><![CDATA[hematology]]></category>
		<category><![CDATA[institute]]></category>
		<category><![CDATA[leukemia]]></category>
		<category><![CDATA[marrow]]></category>
		<category><![CDATA[myeloid]]></category>
		<category><![CDATA[north]]></category>
		<category><![CDATA[novant]]></category>
		<category><![CDATA[oncology]]></category>
		<category><![CDATA[salem]]></category>
		<category><![CDATA[specialist]]></category>
		<category><![CDATA[teacher]]></category>
		<category><![CDATA[therapy]]></category>
		<category><![CDATA[transplant]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[winston]]></category>
		<guid isPermaLink="false">https://goodnewsplanet.com/?p=87062</guid>

					<description><![CDATA[<p>Listen to &#8220;LEUKEMIA IS A TYPE OF CANCER THAT AFFECTS THE BLOOD OR BONE MARROW.&#8221; on Spreaker. LEUKEMIA IS A TYPE OF CANCER THAT AFFECTS THE BLOOD OR BONE MARROW. 1 ONE TYPE IS PHILADELPHIA CHROMOSOME-POSITIVE CHRONIC MYELOID (MY’-uh-loyd) LEUKEMIA. SOME PATIENTS WITH C-M-L MAY HAVE DIFFICULTY FINDING A TREATMENT THAT’S RIGHT FOR THEM. ALMOST &#8230;</p>
<p>The post <a href="https://goodnewsplanet.com/leukemia-is-a-type-of-cancer-that-affects-the-blood-or-bone-marrow/">LEUKEMIA IS A TYPE OF CANCER THAT AFFECTS THE BLOOD OR BONE MARROW.</a> appeared first on <a href="https://goodnewsplanet.com">Good News!</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p style="text-align: center;"><iframe title="YouTube video player" src="https://www.youtube.com/embed/vnmdsbFrGp0?si=wbdwHhCz2p5LhT3w" width="750" height="480" frameborder="0" allowfullscreen="allowfullscreen"></iframe><br />
<a class="spreaker-player" href="https://www.spreaker.com/episode/leukemia-is-a-type-of-cancer-that-affects-the-blood-or-bone-marrow--66369781" data-resource="episode_id=66369781" data-width="100%" data-height="200px" data-theme="light" data-playlist="false" data-playlist-continuous="false" data-chapters-image="true" data-episode-image-position="right" data-hide-logo="false" data-hide-likes="false" data-hide-comments="false" data-hide-sharing="false" data-hide-download="true" data-title="LEUKEMIA IS A TYPE OF CANCER THAT AFFECTS THE BLOOD OR BONE MARROW.">Listen to &#8220;LEUKEMIA IS A TYPE OF CANCER THAT AFFECTS THE BLOOD OR BONE MARROW.&#8221; on Spreaker.</a><br />
<a href="https://goodnewsplanet.com/wp-content/uploads/2025/06/leukemiea_treatment_1.jpg"><img fetchpriority="high" decoding="async" class="size-full wp-image-87063 aligncenter" src="https://goodnewsplanet.com/wp-content/uploads/2025/06/leukemiea_treatment_1.jpg" alt="" width="1920" height="942" srcset="https://goodnewsplanet.com/wp-content/uploads/2025/06/leukemiea_treatment_1.jpg 1920w, https://goodnewsplanet.com/wp-content/uploads/2025/06/leukemiea_treatment_1-300x147.jpg 300w, https://goodnewsplanet.com/wp-content/uploads/2025/06/leukemiea_treatment_1-1024x502.jpg 1024w, https://goodnewsplanet.com/wp-content/uploads/2025/06/leukemiea_treatment_1-768x377.jpg 768w, https://goodnewsplanet.com/wp-content/uploads/2025/06/leukemiea_treatment_1-1536x754.jpg 1536w" sizes="(max-width: 1920px) 100vw, 1920px" /></a></p>
<p>LEUKEMIA IS A TYPE OF CANCER THAT AFFECTS THE BLOOD OR BONE MARROW. 1 ONE TYPE IS PHILADELPHIA CHROMOSOME-POSITIVE CHRONIC MYELOID (MY’-uh-loyd) LEUKEMIA.</p>
<p>SOME PATIENTS WITH C-M-L MAY HAVE DIFFICULTY FINDING A TREATMENT THAT’S RIGHT FOR THEM.</p>
<p>ALMOST 15% OF C-M-L PATIENTS DISCONTINUE THEIR TREATMENT IN THE FIRST YEAR DUE TO SIDE EFFECTS, SO HAVING DIFFERENT OPTIONS IS CRITICAL.3-7</p>
<p>HERE TO SHARE HER OWN EXPERIENCE BEING DIAGNOSED WITH PHILADELPHIA CHROMOSOME-POSITIVE C-M-L IN CHRONIC PHASE AND HOW SHE FOUND A TREATMENT THAT WORKED FOR HER, IS TEACHER AND C-M-L PATIENT, JEN. AND HERE TO TALK ABOUT TREATING ADULTS WITH C-M-L, IS DR. JAMES DUGAN (DOO’-guhn.)</p>
<p>HCP Bio: Dr. James Dugan</p>
<p>Dr. James Dugan is a hematology/oncology specialist, and the physician lead for the transplant and cellular therapy department for Novant Health Cancer Institute in Winston-Salem, North Carolina.</p>
<p>Dr. Dugan was drawn to the field of oncology by the opportunity to improve a person&#8217;s life during a difficult time. He believes that to properly treat the whole person and not just the disease, physicians need to engage in active conversations with the patient throughout the treatment process. Dr. Dugan approaches medicine and oncology as a partnership between the physician and the patient.</p>
<p>Dr. Dugan is a member of the American Society of Hematology, as well as the American Society for Transplant and Cellular therapy. His membership in these organizations keeps him up-to-date on the latest research and treatment options in the field.</p>
<p>When he is not seeing patients, Dr. Dugan enjoys time with his wife and three daughters. He is an outdoor enthusiast who enjoys skiing, scuba diving, kite surfing, and long-distance running. He is passionate about the shared human experience and loves meeting new people and exploring new ideas and places.</p>
<p>Patient Bio: Jen</p>
<p>In 2014, Jen was diagnosed with Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP).<br />
Prior to her diagnosis, Jen devoted her career to serving others. After dedicating 20 years to running inner-city youth programs, Jen became a social worker, supporting women as they rebuilt their lives after incarceration or experiencing domestic violence.<br />
Jen was actively working as a social worker when she was diagnosed with CML. Unfortunately, her diagnosis required her to step away from her career for a period of time. Working closely with her doctor, she navigated the treatment landscape to find a treatment option that worked for her.<br />
Today, she is a teacher in her rural community, educating K-8 students in a one-room schoolhouse. She is also passionate about sharing her journey and advocating for other adults with CML, helping them access the information and support they need to have meaningful conversations with their doctors and navigate their own patient journeys.</p>
<p><a href="http://LearnCML.com">LearnCML.com</a></p>
<p><a class="a2a_button_facebook" href="https://www.addtoany.com/add_to/facebook?linkurl=https%3A%2F%2Fgoodnewsplanet.com%2Fleukemia-is-a-type-of-cancer-that-affects-the-blood-or-bone-marrow%2F&amp;linkname=LEUKEMIA%20IS%20A%20TYPE%20OF%20CANCER%20THAT%20AFFECTS%20THE%20BLOOD%20OR%20BONE%20MARROW." title="Facebook" rel="nofollow noopener" target="_blank"></a><a class="a2a_button_twitter" href="https://www.addtoany.com/add_to/twitter?linkurl=https%3A%2F%2Fgoodnewsplanet.com%2Fleukemia-is-a-type-of-cancer-that-affects-the-blood-or-bone-marrow%2F&amp;linkname=LEUKEMIA%20IS%20A%20TYPE%20OF%20CANCER%20THAT%20AFFECTS%20THE%20BLOOD%20OR%20BONE%20MARROW." title="Twitter" rel="nofollow noopener" target="_blank"></a><a class="a2a_dd addtoany_share_save addtoany_share" href="https://www.addtoany.com/share#url=https%3A%2F%2Fgoodnewsplanet.com%2Fleukemia-is-a-type-of-cancer-that-affects-the-blood-or-bone-marrow%2F&#038;title=LEUKEMIA%20IS%20A%20TYPE%20OF%20CANCER%20THAT%20AFFECTS%20THE%20BLOOD%20OR%20BONE%20MARROW." data-a2a-url="https://goodnewsplanet.com/leukemia-is-a-type-of-cancer-that-affects-the-blood-or-bone-marrow/" data-a2a-title="LEUKEMIA IS A TYPE OF CANCER THAT AFFECTS THE BLOOD OR BONE MARROW."><img src="http://goodnewsplanet.com/images/lg-share-en.gif" alt="Share"></a></p><p>The post <a href="https://goodnewsplanet.com/leukemia-is-a-type-of-cancer-that-affects-the-blood-or-bone-marrow/">LEUKEMIA IS A TYPE OF CANCER THAT AFFECTS THE BLOOD OR BONE MARROW.</a> appeared first on <a href="https://goodnewsplanet.com">Good News!</a>.</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">87062</post-id>	</item>
		<item>
		<title>A leukemia diagnosis is devastating – and when the first steps in a treatment plan fail, patients can wonder what happens next.</title>
		<link>https://goodnewsplanet.com/a-leukemia-diagnosis-is-devastating-and-when-the-first-steps-in-a-treatment-plan-fail-patients-can-wonder-what-happens-next/</link>
		
		<dc:creator><![CDATA[Austin Tang]]></dc:creator>
		<pubDate>Wed, 04 Mar 2020 18:55:41 +0000</pubDate>
				<category><![CDATA[Education]]></category>
		<category><![CDATA[Good News To Go]]></category>
		<category><![CDATA[Good Samaritans]]></category>
		<category><![CDATA[Health and Wellness]]></category>
		<category><![CDATA[Today's Good News]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[center]]></category>
		<category><![CDATA[chronic]]></category>
		<category><![CDATA[cml]]></category>
		<category><![CDATA[diagnosis]]></category>
		<category><![CDATA[education]]></category>
		<category><![CDATA[karen]]></category>
		<category><![CDATA[kettering]]></category>
		<category><![CDATA[leukemia]]></category>
		<category><![CDATA[mauro]]></category>
		<category><![CDATA[medicine]]></category>
		<category><![CDATA[memorial]]></category>
		<category><![CDATA[michael]]></category>
		<category><![CDATA[myeloid]]></category>
		<category><![CDATA[myeloproliferative]]></category>
		<category><![CDATA[need]]></category>
		<category><![CDATA[neoplasms]]></category>
		<category><![CDATA[new]]></category>
		<category><![CDATA[ny]]></category>
		<category><![CDATA[patients]]></category>
		<category><![CDATA[physician]]></category>
		<category><![CDATA[plan]]></category>
		<category><![CDATA[program]]></category>
		<category><![CDATA[sloan]]></category>
		<category><![CDATA[teacher]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[yoga]]></category>
		<category><![CDATA[york]]></category>
		<guid isPermaLink="false">http://goodnewsplanet.com/?p=63820</guid>

					<description><![CDATA[<p>There are a variety of reasons why treatments fail, and patients need to work with their healthcare team to explore their options if treatment failure occurs. Herewith tips for patients, are Dr. Michael Mauro, (More-oh) and Karen, who is living with chronic myeloid leukemia, or CML. BIO:DR. MICHAEL MAURO: • Michael Mauro, MD, Professor of &#8230;</p>
<p>The post <a href="https://goodnewsplanet.com/a-leukemia-diagnosis-is-devastating-and-when-the-first-steps-in-a-treatment-plan-fail-patients-can-wonder-what-happens-next/">A leukemia diagnosis is devastating – and when the first steps in a treatment plan fail, patients can wonder what happens next.</a> appeared first on <a href="https://goodnewsplanet.com">Good News!</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><a href="http://goodnewsplanet.com/wp-content/uploads/2020/03/leukemia_1.jpg"><img decoding="async" src="http://goodnewsplanet.com/wp-content/uploads/2020/03/leukemia_1-300x170.jpg" alt="" width="300" height="170" class="alignnone size-medium wp-image-63822" /></a><br />
<audio class="wp-audio-shortcode" id="audio-63820-1" preload="none" style="width: 100%;" controls="controls"><source type="audio/mpeg" src="http://goodnewsplanet.com/wp-content/uploads/2020/03/leukemia_1.mp3?_=1" /><a href="http://goodnewsplanet.com/wp-content/uploads/2020/03/leukemia_1.mp3">http://goodnewsplanet.com/wp-content/uploads/2020/03/leukemia_1.mp3</a></audio>
<iframe loading="lazy" width="750" height="480" src="https://www.youtube.com/embed/OIjb3XocnrQ" frameborder="0" allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen></iframe><br />
There are a variety of reasons why treatments fail, and patients need to work with their healthcare team to explore their options if treatment failure occurs.<br />
Herewith tips for patients, are Dr. Michael Mauro, (More-oh) and Karen, who is living with chronic myeloid leukemia, or CML.<br />
BIO:DR. MICHAEL MAURO:<br />
•	Michael Mauro, MD, Professor of Medicine, Member and Attending Physician and Leader of the Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, New York, NY<br />
o	Dr. Mauro’s clinical expertise is in treating patients with chronic myeloid leukemia (CML), as well as other myeloproliferative disorders, including myelofibrosis, polycythemia and thrombocytosis. In practice, he offers in-depth explanation regarding diagnoses and therapy options, and is a proponent of active partnerships with his patients to personalize decision-making and monitoring. He is a board-certified hematologist and leader of the Myeloproliferative Neoplasms Program within the Leukemia Service at Memorial Sloan Kettering Cancer Center (MSKCC). Before joining Memorial Sloan Kettering, Dr. Mauro was on the faculty of Oregon Health and Sciences University for 13 years. There, he directed the CML clinical trial program. He completed both residency and fellowship training at New York-Presbyterian Hospital / Weill Cornell Medical College in New York City.<br />
o	Location: Practices in both Manhattan (NYC) and Montvale, NJ campuses of MSKCC<br />
o	Specialty/Areas of Focus: Chronic Myeloid Leukemia; Myelofibrosis; Polycythemia; Thrombocytosis, Other Myeloproliferative Disorders<br />
o	Education: MD, Dartmouth Medical School<br />
o	Board Certifications: Hematology<br />
BIO:KAREN L.<br />
o   Bio: Karen is a teacher, former runner turned yogi, wife and mother of two from Eden Prairie, Minnesota.<br />
o   Journey with CML:<br />
§ When she began losing excessive weight and noticed a weakness in her legs during runs, she initially attributed these symptoms to turning 40 years old. Eventually she decided to visit her doctor, but her doctor was not concerned and told her to come back in a few months if she was still experiencing the same symptoms.<br />
§ A few months later, Karen returned to her doctor for an ultrasound, which revealed her spleen was enlarged. Following a blood test, a nurse called Karen and told her it was suspected she had blood cancer and urged Karen to come straight to the hospital. The nurse expressed concerns about her potentially being at risk for a stroke. After further testing, it was confirmed that Karen had chronic myeloid leukemia (CML). Karen spent several days in the hospital to help regulate the CML. After she was released from the hospital, Karen started taking a daily medication to help control the CML. Eventually Karen was able to return to teaching and her usual activities.<br />
§ Following her initial diagnosis, Karen developed a genetic mutation that caused her treatment for CML to stop working. Since there were no available treatment options effective against the mutation, Karen enrolled in a clinical trial and responded well to the treatment she was given.<br />
§ Today,Karen remains on the medication she took in the clinical trial and is stillteaching.<br />
#leukemia #diagnosis #treatment #plan #patients #need #michael #mauro #cml #chronic #myeloid #karen #medicine #physician #myeloproliferative #neoplasms #program #memorial #sloan #kettering #cancer #center #new #york #ny #teacher #yoga #education</p>
<p><a class="a2a_button_facebook" href="https://www.addtoany.com/add_to/facebook?linkurl=https%3A%2F%2Fgoodnewsplanet.com%2Fa-leukemia-diagnosis-is-devastating-and-when-the-first-steps-in-a-treatment-plan-fail-patients-can-wonder-what-happens-next%2F&amp;linkname=A%20leukemia%20diagnosis%20is%20devastating%20%E2%80%93%20and%20when%20the%20first%20steps%20in%20a%20treatment%20plan%20fail%2C%20patients%20can%20wonder%20what%20happens%20next." title="Facebook" rel="nofollow noopener" target="_blank"></a><a class="a2a_button_twitter" href="https://www.addtoany.com/add_to/twitter?linkurl=https%3A%2F%2Fgoodnewsplanet.com%2Fa-leukemia-diagnosis-is-devastating-and-when-the-first-steps-in-a-treatment-plan-fail-patients-can-wonder-what-happens-next%2F&amp;linkname=A%20leukemia%20diagnosis%20is%20devastating%20%E2%80%93%20and%20when%20the%20first%20steps%20in%20a%20treatment%20plan%20fail%2C%20patients%20can%20wonder%20what%20happens%20next." title="Twitter" rel="nofollow noopener" target="_blank"></a><a class="a2a_dd addtoany_share_save addtoany_share" href="https://www.addtoany.com/share#url=https%3A%2F%2Fgoodnewsplanet.com%2Fa-leukemia-diagnosis-is-devastating-and-when-the-first-steps-in-a-treatment-plan-fail-patients-can-wonder-what-happens-next%2F&#038;title=A%20leukemia%20diagnosis%20is%20devastating%20%E2%80%93%20and%20when%20the%20first%20steps%20in%20a%20treatment%20plan%20fail%2C%20patients%20can%20wonder%20what%20happens%20next." data-a2a-url="https://goodnewsplanet.com/a-leukemia-diagnosis-is-devastating-and-when-the-first-steps-in-a-treatment-plan-fail-patients-can-wonder-what-happens-next/" data-a2a-title="A leukemia diagnosis is devastating – and when the first steps in a treatment plan fail, patients can wonder what happens next."><img src="http://goodnewsplanet.com/images/lg-share-en.gif" alt="Share"></a></p><p>The post <a href="https://goodnewsplanet.com/a-leukemia-diagnosis-is-devastating-and-when-the-first-steps-in-a-treatment-plan-fail-patients-can-wonder-what-happens-next/">A leukemia diagnosis is devastating – and when the first steps in a treatment plan fail, patients can wonder what happens next.</a> appeared first on <a href="https://goodnewsplanet.com">Good News!</a>.</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">63820</post-id>	</item>
	</channel>
</rss>
